Administration of SARS-CoV-2 mRNA vaccine

Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)

procedure
£1.00

Supplier: international · SCTID 1119350007

Also known as (14)
  • 2019 novel coronavirus mRNA immunisation
  • 2019 novel coronavirus mRNA immunization
  • 2019 novel coronavirus mRNA vaccination
  • 2019-nCoV mRNA immunisation
  • 2019-nCoV mRNA immunization
  • 2019-nCoV mRNA vaccination
  • Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid
  • COVID-19 mRNA immunisation
  • COVID-19 mRNA immunization
  • COVID-19 mRNA vaccination
  • SARS-CoV-2 mRNA immunisation
  • SARS-CoV-2 mRNA immunization
  • SARS-CoV-2 mRNA vaccination
  • Severe acute respiratory syndrome coronavirus 2 mRNA vaccination

Found in

Administration of SARS-CoV-2 vaccine

Related products

Administration of fifth dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine
£1.00
Administration of first dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine
£1.00
Administration of fourth dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine
£1.00
Administration of SARS-CoV-2 DNA plasmid encoding spike protein vaccine
£1.00
Administration of SARS-CoV-2 non-replicating viral vector vaccine
£1.00
Administration of second dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine
£1.00
Administration of third dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine
£1.00
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) antigen vaccination
£1.00
Basket
Total£0.00